Filing Details

Accession Number:
0001209191-23-037932
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-16 16:38:53
Reporting Period:
2023-06-15
Accepted Time:
2023-06-16 16:38:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1816160 James Kihara C/O Acadia Pharmaceuticals, Inc.
12830 El Camino Real, Suite 400
San Diego CA 92130
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-15 2,000 $24.15 9,144 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.